Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218198 · ClinicalTrials.gov registry record · NA
Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension
A NA study, sponsored by The Cleveland Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT07218198: Clinical Trial NA study, sponsored by The Cleveland Clinic.
NCT07218198 is a NA study that has not yet begun recruiting, run by The Cleveland Clinic. The registered enrollment target is 168 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07218198, a NA study, has not yet begun recruiting, sponsored by The Cleveland Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared with usual care. The main objective is to assess the impact of the CDS tool, that is embedded with the electronic medical record (EMR), that is available during outpatient clinical encounters, on blood pressure (BP) changes among participants with uncontrolled hypertension. Participants will: Visit the clinic 4 weeks, after their initial clinician visit, for a BP check.
Primary Outcome
Clinical Decision Support (CDS) Tool is available, Change from baseline in systolic automated office blood pressure (AOBP) at 4 weeks.
Interventions
- OTHER Standard medical treatment
- OTHER Clinical Decision Support Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
What is known before NCT07218198 opens enrollment
NCT07218198 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard medical treatment is the first listed.
NCT07218198 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07218198 about?
NCT07218198 is a clinical study titled "Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension". The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared with usual care. The main objective is to assess the impact of the CDS tool, that is embedded with th...
What is the current status of trial NCT07218198?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 168 participants. The study started on 2026-07-01. Estimated completion is 2027-12-01.
What interventions are being tested in trial NCT07218198?
The interventions under investigation include: Standard medical treatment (OTHER), Clinical Decision Support Tool (OTHER).
Who is sponsoring clinical trial NCT07218198?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07218198's enrollment target sits among peer trials
168 619th of 2000 higher than 1,379 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI